Breaking

At 90, the Dalai Lama braces for final showdown with Beijing: his reincarnation
Russia becomes first nation to recognize Taliban government of Afghanistan since 2021 takeover
Two arrested over ‘Chinese blessing scams’ targeting elderly Asian women in Australia
Russia launches record number of drones at Ukraine after latest Trump-Putin phone call
Elephant kills two female tourists from the UK and New Zealand in Zambian national park
What is happening in South Korea? Seoul has caught the lovebug that nobody wants
S&P 500 Earnings for 2025 Q1 — Still Overvalued
Money’s Not Leaving the Market — It’s Rotating!

Business
Investing
Stocks
World
Search for:

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Pinnacle Changes OTC Ticker Symbol to PSGCF

Sun Summit Minerals: Advancing District-scale Gold and Copper Projects in British Columbia

Interview with Executive Chairman

Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (342)
- Investing (1,206)
- Stocks (517)
- World (1,428)

Disclaimer: owninnervoice.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 owninnervoice.com | All Rights Reserved

Top

Business
Investing
Stocks
World

Type above and press Enter to search. Press Esc to cancel.